Hospitalists have had to find new strategies during the pandemic in order to provide optimal care, including company and comfort, to dying inpatients and their families.
The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
A double-blind, randomized controlled trial of 124 ICU patients with septic shock found that while 28-day mortality was lower in those who received IV vitamin C versus placebo, the absolute risk reduction did not reach statistical significance.
The tool used real-time patient data and a trained prediction algorithm to notify the hospitalist if the patient had a high likelihood of nighttime vital sign measurements within reference ranges.
New antipsychotic prescriptions in hospitalized heart failure patients often continued after discharge to SNF
A retrospective cohort study of mostly male veterans found that 10.8% received a new antipsychotic prescription during index hospitalization for heart failure, 21.5% of which were continued after discharge to a skilled nursing facility (SNF).